Estrogen and IGF-1 decrease with age, mediating the activation of osteoclast cytokines, subsequently promoting bone resorption, ultimately leading to osteoporosis [39], and by mediating elevated catabolic cytokine levels, promoting decreased muscle mass and strength, ultimately leading to frailty [40]. This evidence concerns the gene IGF1 and osteoporosis.